Prevention and management of lung cancer in China.
Lung cancer is the leading cause of cancer-related death worldwide. In China, the incidence of lung cancer has grown rapidly, resulting in a large social and economic burden. Several researchers have devoted their studies to lung cancer and have demonstrated that there are many risk factors for lung cancer in China, including tobacco use, environmental pollution, food, genetics, and chronic obstructive pulmonary disease. However, the lung cancer incidence is still growing rapidly in China, and there is an even higher incidence among the younger generation. One explanation may be the triple-neglect situation, in which medical policies that neglect prevention, diagnosis, and supportive care have increased patients' mortality and reduced their quality of life. Therefore, it is necessary to enhance the efficiency of prevention and early diagnosis not only by focusing more attention on treatment but also by drawing more attention to supportive care for patients with lung cancer.
Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Qun-Ying
QY
Hong
Department of Pulmonary Medicine, Xinqiao Hospital, Third Military Medical University, Chongqing, China.
Guo-Ming
GM
Wu
Department of Pulmonary Medicine, Xinqiao Hospital, Third Military Medical University, Chongqing, China.
Gui-Sheng
GS
Qian
Department of Pulmonary Medicine, Xiangya Hospital, Central South University, Changsha, China.
Cheng-Ping
CP
Hu
Department of Pulmonary Medicine, First Affiliated Hospital of College of Medicine, Zhejiang University, Hangzhou, China.
Jian-Ying
JY
Zhou
Department of Pulmonary Medicine, Chinese People's Liberation Army General Hospital, Beijing, China.
Liang-An
LA
Chen
Department of Pulmonary Medicine, West China Hospital, Sichuan University, Chengdu, China.
Wei-Min
WM
Li
State Key Laboratory of Respiratory Disease, Guangzhou Medical University, Guangzhou, China.
Shi-Yue
SY
Li
Department of Pulmonary Medicine, The Second Affiliated Hospital, Zhejiang University, Hangzhou, China.
Kai
K
Wang
Department of Pulmonary Medicine, Second Affiliated Hospital of Dalian Medical University, Dalian, China.
Qi
Q
Wang
Department of Pulmonary Medicine, Zhengzhou University People's Hospital, Zhengzhou, China.
Xiao-Ju
XJ
Zhang
Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Jing
J
Li
Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Xin
X
Gong
Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.|State Key Laboratory of Respiratory Disease, Guangzhou Medical University, Guangzhou, China.
Chun-Xue
CX
Bai
D002681:China; D019468:Disease Management; D006801:Humans; D008175:Lung Neoplasms / Q000453:epidemiology* / Q000473:pathology / Q000517:prevention & control / Q000628:therapy; D029424:Pulmonary Disease, Chronic Obstructive / Q000453:epidemiology* / Q000473:pathology / Q000517:prevention & control / Q000628:therapy; D012307:Risk Factors
chronic obstructive pulmonary disease; lung cancer; management; prevention